A Study to Compare PK, PD and Safety of the AD-213-A and AD-2131

Status:
Suspended

Trial end date:
2022-02-01

Target enrollment:

Participant gender:

A study to compare safety, pharmacokinetics and pharmacodynamics of AD-213-A to AD-2131 in healthy volunteers.

Phase 1

Addpharma Inc.